H.B. Fuller director Daniel L. Florness buys $100,160 in stock

H.B. Fuller executive Daniel L. Florness acquired 2,030 shares of the company's common stock on September 28, 2026, for a total of $100,160. Each share was purchased at $49.34. As a result of this transaction, Mr. Florness now owns 3,381 shares of H.B. Fuller, including the 2,030 shares held jointly with his spouse. The stock price is trading close to its 52-week low of $46.70, currently standing at $48.83.

InvestingPro analysis suggests that H.B. Fuller may be undervalued at present, positioning it among the platform’s most undervalued stocks. The company has a solid track record of raising its dividend for 33 consecutive years, a noteworthy aspect highlighted by several InvestingPro Tips. These tips underscore the financial strength of the adhesives manufacturer.

In addition to his direct stock holdings, Mr. Florness also possesses 33,616.06 stock units. These units will convert into common shares upon events such as his retirement, death, disability, or other specified circumstances, subject to legal holding periods. This total includes stock units acquired through a dividend equivalent feature of the Directors’ Deferred Compensation Plan.

H.B. Fuller recently disclosed its third-quarter financial results, which showed adjusted earnings of $1.52 per share, surpassing analysts' expectations of $1.47 per share. However, revenue fell short of forecasts, amounting to $938 million against the anticipated $948.25 million. Despite the earnings beat, investors expressed concerns about cautious near-term demand trends.

Baird recently adjusted its price target for H.B. Fuller, reducing it from $75 to $65, while maintaining an Outperform rating. Analyst Ghansham Panjabi from Baird based this new target on a projected earnings per share of $5.20 for fiscal 2027.